Pili Ferrer

A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events

Jean‐Luc Faillie, Pili Ferrer, Amandine Gouverneur et al. · Journal of Clinical Epidemiology · 2017 · 51 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use?

Ainhoa Gómez-Lumbreras, Pili Ferrer, Elena Ballarín et al. · Journal of Affective Disorders · 2019 · 38 citations

Medicine, Pharmacotherapy, Psychiatry +13

Sources of European drug consumption data at a country level

Pili Ferrer, Elena Ballarín, Mònica Sabaté et al. · International Journal of Public Health · 2014 · 23 citations

Medicine, Pharmacology, Drug Information +6

A compilation of research working groups on drug utilisation across Europe

Mònica Sabaté, Juan Fernando Pacheco, Elena Ballarín et al. · BMC Research Notes · 2014 · 16 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Tiotropium Respimat^®<i>vs.</i> HandiHaler^®: real‐life usage and TIOSPIR trial generalizability

Sven Schmiedl, Rainald Fischer, Luisa Ibáñez et al. · British Journal of Clinical Pharmacology · 2015 · 12 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13